<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="rss_format.xsl"?>
<rss version="2.0">
<channel>
<title>GSK US news</title>
<link>http://www.us-gsk.com/html/media-news/</link>
<description>GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news.</description>

<item>
<title>GlaxoSmithKline begins distribution of flu vaccine to U.S. customers for 2010-2011 flu season</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10068.htm</link>
<description>GlaxoSmithKline [NYSE: GSK] announced today that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLaval® [Influenza Virus Vaccine] allowing distribution in the U.S. to begin for the 2010-2011 flu season. </description>
<pubDate>Fri, 30 July 2010 14:00:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10068.htm</guid>
</item>

<item>
<title>GlaxoSmithKline to implement new compensation program for U.S. sales professionals</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10067.htm</link>
<description>GlaxoSmithKline [NYSE: GSK] today confirmed that it will implement a new system for evaluating and compensating its sales professionals beginning in 2011.</description>
<pubDate>Mon, 26 Jul 2010 19:00:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10067.htm</guid>
</item>

<item>
<title>GlaxoSmithKline statement in response to FDA announcement on TIDE trial</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10064.htm</link>
<description>GlaxoSmithKline [NYSE: GSK] confirmed today that it will suspend enrollment of new patients in the Thiazolidinedione Intervention with Vitamin D Evaluation (TIDE) clinical trial at the request of the U.S. Food and Drug Administration (FDA) pending FDA  review of recommendations from its Advisory Committee meeting July 13-14.</description>
<pubDate>Wed, 21 Jul 2010 16:15:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10064.htm</guid>
</item>

<item>
<title>GSK announces Q2 2010 results</title>
<link>http://www.gsk.com/investors/quarterly_results.htm</link>
<description>Q2 EPS before major restructuring 2.6p (29.3p excluding pre-announced legal charge)</description>
<pubDate>Wed, 21 Jul 2010 12:00:00 GMT</pubDate>
<guid>http://www.gsk.com/investors/quarterly_results.htm</guid>
</item>

<item>
<title>Update to 2009 Notification of Stolen Advair Diskus Inhalers</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10061.htm</link>
<description>A small number of Advair Diskus inhalers stolen from a GlaxoSmithKline distribution warehouse in 2009 have been found in some pharmacies.</description>
<pubDate>Fri, 16 July 2010 16:00:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10061.htm</guid>
</item>

<item>
<title>Stiefel, a GSK company, Receives FDA Approval of VELTIN™ (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10060.htm</link>
<description>Stiefel, a GSK company, today announced that the U.S. Food and Drug Administration (FDA) has approved VELTIN Gel for the topical treatment of acne vulgaris in patients 12 years and older.</description>
<pubDate>Fri, 16 July 2010 14:15:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10060.htm</guid>
</item>

<item>
<title>GlaxoSmithKline statement in response to FDA Advisory Committees’ vote on safety of Avandia® (rosiglitazone)</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10059.htm</link>
<description>GlaxoSmithKline [NYSE: GSK] confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market.</description>
<pubDate>Wed, 14 July 2010 21:15:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10059.htm</guid>
</item>

<item>
<title>GlaxoSmithKline (GSK) responds to Senate Finance Committee letter of 12 July to FDA</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10075.htm</link>
<description>The Senate Finance Committee (SFC) has released a small subset of the 14 million pages of documents provided to plaintiffs' counsel in the product liability litigation.</description>
<pubDate>Tue, 13 July 2010 14:00:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_pressrelease_10075.htm</guid>
</item>

<item>
<title>GlaxoSmithKline and XenoPort report top-line phase 2b results for GSK1838262/XP13512 as a prophylactic treatment for migraine headache</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10052.htm</link>
<description>GlaxoSmithKline and XenoPort, Inc. announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches.</description>
<pubDate>Wed, 7 July 2010 12:45:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10052.htm</guid>
</item>

<item>
<title>BC and Goody’s online “Pick A Powder” contest kicks off starring Trace Adkins and Richard Petty</title>
<link>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10040.htm</link>
<description>Humorous Collection Of Short Videos Showing Them In Each Other’s World Is At The Heart Of The Campaign Along With A Charity Tie</description>
<pubDate>Thu, 1 July 2010 15:00:00 GMT</pubDate>
<guid>http://us.gsk.com/html/media-news/pressreleases/2010/2010_us_pressrelease_10040.htm</guid>
</item>

</channel>
</rss>